Hematology News

David R. Green, MSA, has been installed as president of AABB for the 2020-2021 term.

Toxicity on spermatogenesis may not be a major concern for boys with severe sickle cell disease who require hydroxyurea treatment before puberty, according to results of a study published in Blood.

ASH announced the election of four new members to its executive committee.

Children undergoing hematopoietic stem cell transplants for cancer had higher rates of transplant-related mortality if they lived in a poorer neighborhood, according to results of a study published in Blood.

The FDA granted orphan drug designation to CSL889 for the treatment of sickle cell disease, according to the agent’s manufacturer.

Researchers reported recently in The BMJ that convalescent plasma was not associated with a reduction in progression to severe COVID-19 or all-cause mortality in adults with moderate disease.

Anthony S. Fauci, MD will be a keynote speaker during a special session at this year’s virtual ASH Annual Meeting and Exposition.

Congenital plasminogen deficiency is an extremely rare disorder characterized by development of fibrinous or woody pseudomembranes that typically accumulate on mucosal surfaces.

Referring only patients with a positive D-dimer test to undergo compression ultrasonography, regardless of pretest probability, safely simplified the workup of deep vein thrombosis, according to study results published in Blood Advances.

People with blood type O may be less likely to develop COVID-19 infection, and they may have a lower risk for severe outcomes if they contract the virus, according to results of two studies published in Blood Advances.